share_log

Calithera Biosciences | DEFM14A: Definitive proxy statement relating to merger or acquisition

SEC announcement ·  Jun 5, 2023 17:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more